HomeRAPH • OTCMKTS
add
Raphael Pharmaceutical Inc
Previous close
$1.65
Year range
$0.60 - $1.67
Market cap
30.79M USD
Avg Volume
55.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 547.00K | 112.02% |
Net income | -550.00K | -108.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 287.00K | 655.26% |
Total assets | 353.00K | 135.33% |
Total liabilities | 456.00K | 186.79% |
Total equity | -103.00K | — |
Shares outstanding | 18.66M | — |
Price to book | -165.00 | — |
Return on assets | -395.23% | — |
Return on capital | -1,667.68% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -550.00K | -108.33% |
Cash from operations | -172.00K | 56.89% |
Cash from investing | -1.00K | — |
Cash from financing | 230.00K | 54.36% |
Net change in cash | 57.00K | 122.80% |
Free cash flow | 83.25K | 127.75% |
About
Founded
2007
Headquarters
Website